Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.59 |
| ▸ | GLA | P06280 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6920739 | 0.84 | ALDH1A1 (0.50) | ALDH1A1GLATSHRMEN1KMT2A | |
| SCHEMBL11362769 | 0.83 | ALDH1A1 (0.46) | ALDH1A1GLATSHRMEN1KMT2A | |
| SCHEMBL1276930 | 0.83 | ALDH1A1 (0.63) | ALDH1A1GLATSHRMEN1KMT2A | |
| SCHEMBL11423478 | 0.83 | ALDH1A1 (0.63) | ALDH1A1GLATSHRMEN1KMT2A | |
| SCHEMBL4603063 | 0.83 | ALDH1A1 (0.63) | ALDH1A1GLATSHRMEN1KMT2A | |
| SCHEMBL28076543 | 0.81 | NPC1 (0.50) | ALDH1A1GLATSHRMEN1KMT2A | |
| SCHEMBL27552754 | 0.81 | ALDH1A1 (0.56) | ALDH1A1GLATSHRMEN1KMT2A | |
| SCHEMBL5458866 | 0.81 | ALDH1A1 (0.61) | ALDH1A1GLATSHRMEN1KMT2A | |
| SCHEMBL8611486 | 0.80 | ALDH1A1 (0.43) | ALDH1A1GLATSHRMEN1KMT2A | |
| SCHEMBL10417492 | 0.80 | NPC1 (0.56) | ALDH1A1GLATSHRMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-223019684-U | EPTU steady-state drain pipe joint | 贵阳伟佳塑料有限公司 | 2025-06-24 | — | — | CN | claimed |
| CN-222548925-U | Novel multifunctional mattress | 河南欧菲克新材料有限公司 | 2025-03-04 | — | — | CN | claimed |
| CN-221729868-U | High-resilience breathable comfortable EPTU insole | 福建省华志新材料科技有限公司 | 2024-09-20 | — | — | CN | claimed |
| US-20250351828-A1 | AZOLE FUNGICIDE COMPOSITION | ADAMA MAKHTESHIM LTD. (IL) | 2025-11-20 | — | — | US | disclosed |
| EP-4644188-A1 | GUARD PLATE AND VEHICLE | BYD Company Limited (CN) | 2025-11-05 | — | — | EP | disclosed |
| US-20250323369-A1 | GUARD PLATE AND VEHICLE | BYD CO LTD (CN) | 2025-10-16 | — | — | US | disclosed |
| CN-223076463-U | EPTU steady-state anti-seismic drain pipe | 贵阳伟佳塑料有限公司 | 2025-07-08 | — | — | CN | disclosed |
| CN-223076463-U | EPTU steady-state anti-seismic drain pipe | 贵阳伟佳塑料有限公司 | 2025-07-08 | — | — | CN | disclosed |
| CN-223019684-U | EPTU steady-state drain pipe joint | 贵阳伟佳塑料有限公司 | 2025-06-24 | — | — | CN | disclosed |
| CN-223019684-U | EPTU steady-state drain pipe joint | 贵阳伟佳塑料有限公司 | 2025-06-24 | — | — | CN | disclosed |
| CN-223019684-U | EPTU steady-state drain pipe joint | 贵阳伟佳塑料有限公司 | 2025-06-24 | — | — | CN | disclosed |
| US-5864043-A | CARDIOVASCULAR DISORDERS AND ANGIOTENSIN ANTAGONIST | KARL THOMAE GMBH (DE) | 1999-01-26 | — | — | US | disclosed |
| US-5541229-A | ANGIOITENSIN II ANTAGONIST AS HYPOTENSIVE AGENTS, ANTIISCHEMIC AGENTS AND CARDIOVASCULAR DISORDERS | DR. KARL THOMAE GMBH (DE) | 1996-07-30 | — | — | US | disclosed |
| US-5153331-A | Reacting 6-epoxyethyl-3-oxatricyclo 3.2.1.0(2,4)!octane with a thiocyanate salt and/or a thiourea | NIPPON OIL COMPANY, LTD. (JP) | 1992-10-06 | — | — | US | disclosed |
| EP-0452092-A2 | 6-Epithioethyl-3-oxatricyclo (3.2.1.02.4) octane and process for preparation thereof | NIPPON OIL CO. LTD. (JP) | 1991-10-16 | — | — | EP | disclosed |
| US-4891069-A | CATALYST FOR REDUCTION OF METAL COMPOUND BY GENERATED HYDROGEN | TECHNO INSTRUMENTS INVESTMENTS 1983 LTD. (IL) | 1990-01-02 | — | — | US | disclosed |
| US-4790912-A | ELECTROLYTICALLY-GENERATED HYDROGEN AND CATALYST CONVERT METAL SALT IN BATH TO METAL | TECHNO-INSTRUMENTS INVESTMENTS LTD. (IL) | 1988-12-13 | — | — | US | disclosed |
| US-4749449-A | PLATING ON CATALYZED THROUGH HOLE WALL IN PATTERENED CONDUCTIVE AND INSULATING LAYERS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-06-07 | — | — | US | disclosed |
| US-4293391-A | Cadmium plating baths and methods for electrodepositing bright cadmium deposits | ROHCO, INC. (US) | 1981-10-06 | — | — | US | disclosed |
| US-4252963-A | CYCLIZATION OF PHENYLTHIOUREAS WITH THIONYL CHLORIDE | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250351828-A1 | AZOLE FUNGICIDE COMPOSITION | TST, PIK3C3, TPMT | ALDH1A1 2151/4885GLA 4517/4885TSHR 801/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.